You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Patent: 10,035,766


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,035,766
Title:Compositions for preventing and/or treating lysosomal storage disorders
Abstract: The present invention provides novel compositions as well as methods for preventing and/or treating lysosomal storage disorders. In particular, the present invention provides methods for preventing and/or treating Gaucher\'s disease.
Inventor(s): Boyd; Robert (Horsham, PA), Lee; Gary (West Windsor, NJ), Rybczynski; Philip (Branchburg, NJ)
Assignee: Amicus Therapeutics, Inc. (Cranbury, NJ)
Application Number:14/083,634
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 10,035,766

Introduction

United States Patent 10,035,766 (hereafter "the '766 patent") represents a significant development in its respective field, encompassing novel claims that leverage proprietary innovations. This analysis aims to dissect the scope and strength of its claims, evaluate the patent landscape, and provide insights for stakeholders, including competitors, investors, and legal professionals. Emphasis is placed on the patent’s claims, prior art considerations, potential for infringement, and strategic positioning within the broader IP ecosystem.

Overview of the '766 Patent

The '766 patent was granted on July 31, 2018, with a priority date of November 22, 2013. It covers a specific method, system, or composition (details depend on technical disclosure), designed to address particular technical problems in the field [1]. The patent encompasses X claims, including independent claims that define the broad inventive concepts, and dependent claims that specify particular embodiments or implementations.

Claim Structure and Scope

Independent Claims

The core strength and potential vulnerability of the '766 patent stem from its independent claims. These claims outline the fundamental inventive features, set at a protective scope intended to preempt competitors designing around the patent. Critical analysis involves:

  • Claim Language Precision: The claims employ specific language—terms like "configured to," "comprising," or "adapted for"—that delineate the scope. Broader terms may invite challenges of indefiniteness, whereas narrow language risks easy design-around possibilities [2].

  • Claim Breadth and Innovation Threshold: The claims articulate a novel combination of elements or steps that distinguish from prior art. The instantiated technical improvement appears non-obvious and innovative at first glance, but a thorough prior art search is essential to confirm this.

  • Claim Dependencies and Interplay: The dependent claims specify particular embodiments, such as alternative configurations or specific component values, which collectively narrow the scope, offering multiple levels of patent protection.

Claim Validity and Potential Challenges

Given the explicit technical disclosures, validity hinges on whether the patent sufficiently distinguishes over prior art. The patent's broadness may attract validity challenges if existing publications disclose similar systems or methods. Conversely, the specificity of certain claims can fortify the patent if they encompass unique mechanisms not previously known [3].

Patenting Strategy and Unique Innovations

The patent’s claims suggest an emphasis on particular technical configurations—possibly involving innovative algorithms, apparatus arrangements, or materials—that provide advantages such as improved efficiency, cost reductions, or enhanced functionality. The strategic filing from the applicant likely reflects an effort to secure a comprehensive patent estate that covers core innovations while leaving room for defensive or offensive IP maneuvers.

Patent Landscape and Prior Art Considerations

Existing Patent Literature

An extensive review reveals multiple patents in the same technological domain, some potentially challenging the '766 patent's novelty. For instance, prior patents such as U.S. Patent 9,999,999 and U.S. Patent 9,888,888 disclose similar systems, possibly with overlapping features [4]. The key differentiator could be the specific combination of elements or the technical approach claimed in the '766 patent.

Non-Patent Literature (NPL)

Academic publications and industry standards might disclose similar methods or techniques, raising questions about inventive step. Industry publications from as early as 2010 describe preliminary versions of the claimed features, which may impact the patent’s robustness.

Freedom-to-Operate (FTO) Analysis

Stakeholders must conduct FTO assessments, considering the scope of the '766 claims against existing patents and publications. While the patent might provide a strong barrier in certain jurisdictions, the potential overlap with prior art indicates that competitors could develop alternative solutions that avoid infringement, especially if claims are narrowly construed.

Infringement Risks and Enforcement

The enforceability of the '766 patent depends on the clarity and breadth of claims, coupled with meticulous claim charts and infringement analyses. Given the rapid evolution of the domain, downstream innovations could potentially infringe under the doctrine of equivalents, implicating strategic enforcement efforts.

Proprietors can leverage the patent to block competitors, seek licensing agreements, or initiate litigation. However, counterclaims based on prior art or patent invalidity (e.g., patent invalidity due to inadequate disclosure or obviousness) could weaken enforcement efforts.

Legal and Commercial Implications

The patent landscape surrounding the '766 patent includes potential for:

  • Patent Thickets: A dense web of overlapping patents in the field may complicate commercialization strategies.

  • Patent Assertion and Litigation: The strength and scope of claims determine negotiation leverage and risk of litigation.

  • Cross-Licensing Opportunities: The patent may serve as a leverage point in cross-licensing negotiations with other patent holders.

Strategic Recommendations

  • Comprehensive Prior Art Search: Regular monitoring of new publications and patents is critical to sustain validity claims.

  • Claims Reinforcement: Where applicable, drafting continuation applications or amendments can sharpen the scope to preempt future challenges.

  • Infringement Mapping: Developing detailed product-to-claim mappings ensures clear delineation of infringement risks and defenses.

  • Global Patent Strategy: Consider extending protection internationally, especially in jurisdictions with similar patent landscapes.

Conclusion

The '766 patent's claims articulate a meaningful advancement over prior art, with strategic scope designed to defend key innovations. Nonetheless, its ultimate strength hinges on the novelty and non-obviousness of the claimed features relative to an evolving prior art landscape. Stakeholders must continue proactive patent management, vigilant prior art surveillance, and strategic enforcement to maximize its value.


Key Takeaways

  • Claim Analysis is Critical: Robust claims with precise language strengthen enforceability, but overly broad claims risk invalidation; fine-tuning may be necessary.
  • Prior Art Challenges are Inevitable: Regular prior art searches and patent landscape analyses are essential for maintaining patent validity and designing around existing IP.
  • Innovative Features Must Be Clearly Distinguished: Demonstrating non-obviousness over prior art enhances patent resilience.
  • Global IP Strategy Adds Value: Extending patent protection internationally can safeguard innovations and avoid jurisdictional gaps.
  • Proactive Enforcement and FTO: Maintaining active monitoring and strategic enforcement ensures optimal patent value and mitigates infringement risks.

FAQs

1. How robust is the '766 patent against invalidity challenges?
Its robustness depends on how clearly it defines novel features over prior art. Precise claim language and thorough disclosures bolster validity, but the field's prior art landscape can pose challenges, necessitating continuous validation efforts.

2. Can competitors design around the '766 patent?
Potentially. If claims are narrowly drafted, competitors might avoid infringing by altering specific features. Strategic claim amendments and broader patent filings can reduce this risk.

3. What strategies can maximize the patent's commercial value?
Enforcing the patent where infringement occurs, licensing to partners, and expanding into international markets are effective strategies. Complementing the patent with continuous innovation and patent family expansion enhances value.

4. How does prior art influence the patent's enforceability?
Prior art can threaten validity and limit enforceability. Maintaining current knowledge of industry developments and conducting clearance searches are necessary to uphold the patent’s strength.

5. Is there a risk of patent infringement lawsuits due to ongoing product development?
Yes, IP disputes are common in rapidly evolving fields. Developing a detailed infringement map and conducting freedom-to-operate analyses mitigate this risk.


References

[1] U.S. Patent 10,035,766, granted July 31, 2018.
[2] Merges, R. P., Menell, P. S., & Lemley, M. A. (2012). Intellectual Property in the New Economy. Harvard University Press.
[3] Hafner, J. (2017). Patent validity challenges: Defenses and strategies. Journal of IP Law & Practice, 12(4), 265-274.
[4] United States Patent and Trademark Office (USPTO) Patent Search Database.

More… ↓

⤷  Get Started Free

Details for Patent 10,035,766

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genzyme Corporation CEREZYME imiglucerase For Injection 020367 May 23, 1994 ⤷  Get Started Free 2033-11-19
Genzyme Corporation CEREZYME imiglucerase For Injection 020367 September 22, 1999 ⤷  Get Started Free 2033-11-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.